Another Colorado Cannabis Company Attempts to Snare Mile High Stadium Naming Rights

o.penvape mile high stadium

O.penVAPE Bids for Broncos Stadium Naming Rights

Lead Cannabis Brand Promotes Mainstream Acceptance and NFL Wellness Alternative

DENVER, CO–(Marketwired – May 19, 2016) – O.penVAPE recently submitted a proposal to partner with the Metropolitan Football Stadium District, home of the Denver Broncos, to sponsor Denver’s landmark stadium. Headquartered in Denver, the nation’s leading vaporizer and cannabis oil company envisions the stadium sponsorship as a platform to promote its non-psychoactive cannabidiol (CBD) wellness products.

The current assignee of the stadium’s naming rights, Sports Authority, recently announced it will be forced to sell its assets after failing to reach an agreement with creditors. The proposal from O.penVAPE states that the company has the financial means to assume the obligations of the current naming agreement, which may cost more than $6 million annually, in a deal expected to last until 2021.

Coincidentally, a bipartisan bill introduced into the Colorado legislature in April hopes to ensure the name “Mile High” will live on as part of any naming deal for the Denver Broncos’ stadium. Jeremy Heidl, Chief Operating Officer, said O.penVAPE intends to preserve that legacy by pursuing “O.penVAPE at Mile High” as the stadium’s official designation.

“We’re a rapidly growing global business, and we see the opportunity to align two iconic winning Colorado brands to reflect our state’s pioneering spirit and heritage,” Heidl said. “Our company produces much more than innovative vape pens, and we intend to drive awareness around the use of CBD products as an alternative treatment for pain and other medical conditions, an issue specifically relevant to the NFL.”

Heidl said a growing number of grassroots organizations advocate for NFL players to use cannabis, and CBD in particular, to treat pain, inflammation, seizures, hypertension, chronic traumatic encephalopathy (CTE) and other medical issues. The Denver Post recently reported that a group of retired NFL players, led by former Broncos Nate Jackson and Jake Plummer, as well as current Ravens tackle Eugene Monroe, are lobbying to relax NFL restrictions and disciplinary actions against players’ use of cannabis. The Post reported those players believe cannabis derived products offer a safer and more effective alternative to the addictive narcotic painkillers players receive while in the league.

Lance Johnstone, a former Oakland Raider and Minnesota Viking defensive end, concurs. As a spokesman for the Gridiron Cannabis Coalition, Johnstone also works with Timeless Herbal Care, O.penVAPE’s licensee in Jamaica, to conduct clinical trials with former players for concussive injury and pain management.

“The NFL has the opportunity to be a leader in the sports industry to address pain management,” Johnstone said. “I believe many active and retired players would appreciate working with O.penVAPE to support scientific research, dispel the stigmas of using cannabis, and provide safer treatment alternatives to league players.”

It was the existing collaboration with Johnstone and the opportunity at hand that lead to the O.penVAPE bid for naming rights. Heidl said national cannabis legalization, and more importantly, safe access to legal cannabis is imminent.

“Pennsylvania has become the 24th state to legalize medical marijuana and Federal legalization will happen in the near future,” Heidl said. “O.penVAPE is ready and well positioned to lead research and innovation.”

O.penVAPE has committed resources to actively lead CBD innovation research and development. It has invested in a scientific team that is driving technology to measure oils in convenient, consistent and measurable doses. In addition, it recently announced its CBD Biosciences venture in Pueblo, CO. Taxpayers approved approximately $8 million in economic stimulus funding to O.penVAPE and its partners to create jobs and to refurbish a former Boeing rocket assembly plant as a hemp oil processing and CBD scientific research facility.

About O.penVAPE

With products in more than 1,100 dispensaries worldwide, O.penVAPE has established itself as the global leader within the cannabis industry. O.penVAPE appreciates a mutually beneficial relationship with its network of affiliates who are licensed to manufacture and sell O.penVAPE cartridges, vaporizer devices and other related products. Licensees in Arizona, California, Colorado, Maine, Massachusetts, Nevada, New Mexico, Oregon and Connecticut employ O.penVAPE’s Organa Labs technology to manufacture cannabis oil through supercritical CO2 extraction. Now, medical marijuana patients and cannabis enthusiasts have broader access to a pure, safer and more consistent product. O.penVAPE’s leaders ardently support cannabis legalization and scientific research in order to provide better, alternative medicine. Please visit for more information.

Ann Dickerson National Concessions Group, Inc. 1058 Delaware St. Denver, CO 80204 PH: 303-319-4330 Email:

Original press release:

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter